The similarity in shifts of calcium affinity, release mode, and size distribution lead us to conclude that T1D-mimicking cytokine treatment results in loss of syt7 granules, whereas T2D-mimicking palmitate treatment results in loss of syt9 granules. This evidence concerns the gene SYT9 and type 2 diabetes mellitus.